These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
158 related articles for article (PubMed ID: 7900021)
1. [Antioxidants in the combined therapy of patients with chronic destructive pulmonary tuberculosis]. Ivanova LA; Pavlova MV; Archakova LI Ter Arkh; 1994; 66(11):54-6. PubMed ID: 7900021 [TBL] [Abstract][Full Text] [Related]
2. [Use of different regimes of etiopathogenetic therapy in pulmonary tuberculosis in adolescents]. Pavlova MV Probl Tuberk; 1995; (5):30-2. PubMed ID: 7567888 [TBL] [Abstract][Full Text] [Related]
5. [Chemotherapy of destructive pulmonary tuberculosis with antioxidants and antihypoxic agents]. Savula MM; Kravchenko NS; Poznanskiĭ AI Probl Tuberk; 1993; (5):18-20. PubMed ID: 8295877 [TBL] [Abstract][Full Text] [Related]
6. [The use of the antihypoxants olifen and amtizol for treating patients with chronic stage-IIB circulatory failure]. Andrianov VP; Boĭtsov SA; Smirnov AV; Shalin IM; Tomchin AB; Zakharova AI; Ivanova VA; Bulyko TM Ter Arkh; 1996; 68(5):74-8. PubMed ID: 9082608 [TBL] [Abstract][Full Text] [Related]
7. [Indications for the use of prednisolone in tuberculosis]. Starostenko EV; Novoselova VP Probl Tuberk; 1989; (1):44-7. PubMed ID: 2654922 [TBL] [Abstract][Full Text] [Related]
8. [Effect of antioxidants on lipid peroxidation and on liver function in patients with pulmonary tuberculosis]. Skakun NL; Blikhar EI Farmakol Toksikol; 1986; 49(5):112-4. PubMed ID: 3770163 [TBL] [Abstract][Full Text] [Related]
10. [Intermittent polychemotherapy of patients with chronic destructive pulmonary tuberculosis with associated diabetes mellitus]. Cheren'ko SA Probl Tuberk; 1989; (8):48-50. PubMed ID: 2813313 [TBL] [Abstract][Full Text] [Related]
11. [Antioxidants--effective pathogenetic agents in the combined therapy of pulmonary tuberculosis]. Gur'eva IG; Starostenko EV; Narovlianskaia SE Ter Arkh; 1987; 59(7):72-4. PubMed ID: 3672365 [TBL] [Abstract][Full Text] [Related]
12. [A clinico-pharmacological study of olifen in periodontal inflammation]. Turgeneva LB; Novikov VE; Tsenov LM Eksp Klin Farmakol; 1997; 60(2):75-7. PubMed ID: 9206579 [TBL] [Abstract][Full Text] [Related]
13. [Antioxidants in the treatment of patients with discoid lupus erythematosus]. Kalamkarian AA; Samsonov VA; Olisova MO; Lashmanova AP; Polianskaia NP Vestn Dermatol Venerol; 1989; (10):29-31. PubMed ID: 2609744 [TBL] [Abstract][Full Text] [Related]
14. [The tuberculostatic test in patients with chronic destructive pulmonary tuberculosis during chemotherapy with ethambutol combined with drugs of the first and second series]. Adamovich VN; Gur'ian IE; Reĭderman IB; Deev AD Antibiotiki; 1974 Apr; 19(4):371-4. PubMed ID: 4463877 [No Abstract] [Full Text] [Related]
15. [Chemotherapy effectiveness in chronic and hyperchronic forms of destructive pulmonary tuberculosis]. Kartoziia LS Probl Tuberk; 1981 Apr; (4):32-5. PubMed ID: 7255373 [No Abstract] [Full Text] [Related]
16. [Specific features of diagnosis and treatment of patients with pulmonary sarcoidosis and tuberculosis]. Kostina ZI; Brazhenko NA; Gerasimova EV; Kol'nikova OV Probl Tuberk; 1998; (2):10-3. PubMed ID: 9613175 [TBL] [Abstract][Full Text] [Related]
17. [The comprehensive diagnosis and therapy of nonspecific bronchitis in patients with newly detected pulmonary tuberculosis]. Krasnov VA; Potashova VA; Kozhevnikov NN; Naryshkina SL; Zhukova EM; Platov SI; Lirman GA Probl Tuberk; 1993; (1):19-21. PubMed ID: 8327430 [TBL] [Abstract][Full Text] [Related]